Intragastric pH monitoring is an impor− tant tool for assessing the pharmacody− namic profiles of antisecretory agents [1] .
Ambulatory 24−hour intragastric pH monitoring is usually done by means of an antimony or glass electrode that is placed transnasally. Limitations of cathe− ter−based pH monitoring include discom− fort, inconvenience, and interference with normal activity for patients. In addition, precise placement of the pH electrode is crucial for the method, with manometry being required to locate the position of the lower esophageal sphincter [2] .
The Medtronic Bravo pH Monitoring Sys− tem (Medtronic, Vadodara, Gujarat) is a new US Food and Drug Administration (FDA) class 1−approved catheter−free esophageal pH monitoring system that involves the attachment of a radio tele− metry capsule to the mucosal wall [3] . There are no published data on the use of the new Bravo system for intragastric pH monitoring. We hereby report on the safe− ty, performance, and tolerability of this wireless recording system for intragastric pH when the capsule is implanted under endoscopic guidance.
A 26−year−old asymptomatic healthy male volunteer was enrolled. The capsule delivery system was passed orally under endoscopic guidance, with the patient in the left lateral decubitus position. The gastroesophageal junction was first lo− cated by endoscopy and then the delivery system was advanced under direct vision so that the pH electrode was at the greater curvature about 10 cm below the squa− mocolumnar junction. The capsule was then secured to the gastric mucosa fol− lowing the standard instructions in the user manual (Figure 1) .
A 24−hr baseline pH was recorded as the volunteer continued his regular activities. He fasted for the next 24 hours and intra− venous rabeprazole given according to the study protocol. On completion of record− ing, the data were uploaded to a computer via datalink (Medtronic) and a summary of the pH data was generated (Figure 2 ). This endoscopy−assisted wireless ambu− latory pH recording system appears to be a well−tolerated, reliable means of moni− toring intragastric pH. The endoscopic vi− sualization ensures uniform and accurate positioning and avoids local trauma dur− ing placement. The mucosal attachment of the electrode virtually eliminates the possibility of recording artifacts related to relative movement between the pH electrode and the mucosa during the monitoring period. This refinement in methodology will permit broader use of intragastric pH monitoring.
